Market news.

Tether's USDT stablecoin shed more than $1.1 billion in market capitalization in a single day, underscoring mounting liquidity pressures across the cryptocurrency market as institutional investors pull back risk and capital rotates toward regulated alternatives.

The quantum computing trade has shifted from a speculative bet to an identifiable, investable theme, and the three exchange-traded funds that best capture it each take a different angle on the same transition.

Stellar (XLM), XRP, and Tether emerge as weekend's most talked-about digital assets.

Investor interest in the AI space continues to grow, with many focusing on AI infrastructure plays to meet the increasing demand for data centers or on semiconductor stocks building the components necessary for AI platforms to function. One potentially overlooked area that is vital to AI but not directly related to the technology itself is land.

There is a question that, in the most devout cryptocurrency circles, sounds almost heretical: would Ethereum survive decentralization? Posed this way, it seems nonsensical, because Ethereum is not a company that can be “decentralized”; it is, by design, a social and technical machinery built to function without masters.

The prolonged four-month calm on the crypto market is likely coming to an end. At least that is what popular CryptoQuant on-chain analyst Maartunn warned investors about, pointing to an inevitable and abrupt breakout of Bitcoin from its current trading range.

Leverage dynamics and weak price action are reviving speculation concerns around ETH accumulation.

More than 1.5 million SHIB were burned in the last 24 hours; however, the SHIB burn rate failed to rise. The Shiba Inu daily burn rate remained in the red as even fewer SHIB were burned from the past day.

/PRNewswire/ -- United Imaging, a global innovator in AI-powered advanced medical imaging technologies and intelligent healthcare solutions, is presenting its

/PRNewswire/ -- Kulani Kinis made its Miami Swim Week debut on 30 May with "Endless," an immersive runway experience at the PARAISO Fashion Tent that brought

Despite pressures on the cruise industry because of geopolitics and the oil price shock, the Viking Holdings' stock continues to rise unabated. The company's double-digit percent revenue growth and expanding adjusted EBITDA in Q1 2026 work in its favour, even as there has been a seasonal net loss. A resolution to the war can support the company's fundamentals even more, though its stock price can see a short-term dip then as investors interest moves towards sector laggards.

American Express differs from other credit card companies, and its model gives it a durable competitive edge. American Express stock has soundly beaten Visa and Mastercard, as well as the S&P 500, over the past five years.

Ford (NYSE:F | F Price Prediction) and General Motors (NYSE:GM) closed Q1 2026 with a sharp contrast.

Messari says XRP price fell 27% in Q1, while XRPL transactions rose 35% and RWA market cap jumped 124% to $2.25B.

Strategy's next bitcoin buy speculation resumed after Michael Saylor shared an orange-dot chart showing 843,738 BTC and a $62.24 billion reserve value. The post renewed focus on prior chart patterns, liquidity signals, and whether another purchase disclosure could follow.

Inflation has a way of turning economics into personal finance. For retirees living on fixed incomes, every increase in the price of groceries, gasoline, utilities, and healthcare stretches a monthly Social Security check a little further than it was designed to go. And after years of inflation shocks, Americans are once again watching prices climb.... Trump and Kevin Warsh Plan a Huge Giveaway to Retirees. There's Only One Problem

Comfort Systems USA rated BUY with a $2,150 12-month price target, leveraging a recent 14% correction as an attractive entry into a secular growth story. FIX's growth is underpinned by surging AI data center construction and US manufacturing reshoring, with technology clients now 56% of Q1 2026 revenues. Revenues surged 29.5% in 2025 and 56% YoY in Q1 2026, with gross margins expanding to 24.1% and a record $12.5Bn backlog driven by strong order intake.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026, inclusive (the "Class Period"), of the important July 6, 2026 lead plaintiff deadline.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026, inclusive (the "Class Period"), of the important July 6, 2026 lead plaintiff deadline.

Picture a 67-year-old who cleaned hotel rooms in her 30s, ran a cash register through her 40s, and spent her 50s in a diner kitchen. Thirty years of steady work, almost none above $25,000 a year. Now she stares at her Social Security statement and wonders if that is really all the system has for... Social Security's Special Minimum Benefit is Disappearing. Here's Who Still Qualifies in 2026

AltaGas: Switch From Common Shares To Preferred Stock For A Strong 3-Year Return

SpaceX is seen by some as an amazing opportunity to benefit from what will be the largest IPO to date. I clearly do not share this optimism. Decades of experience in the securities industry lead me to prefer substance over hype. My opening paragraph shows my thesis as to why I am avoiding the hoopla surrounding the SpaceX IPO.

Meta Platforms (NASDAQ:META | META Price Prediction) just reported one of the strangest quarters in mega-cap tech.

This digital manufacturing platform, serving diverse industries, reported a notable insider sale amid strong one-year stock performance.

WLD rose after World ID ticket access news, hitting $0.38 before cooling near $0.33 as traders watch $0.30 support and $0.45 resistance.

Philadelphia, Pennsylvania--(Newsfile Corp. - May 31, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Zoetis, Inc. (NYSE: ZTS).

Bittensor's live subnet economy and fixed 21M token supply challenge how markets currently price TAO

CALGARY, AB, May 31, 2026 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) today said it has implemented contingency plans to maintain railway operations across Canada following the International Brotherhood of Electrical Worker (IBEW) Canadian Signals and Communications System Council No. 11's rejection of CPKC's latest contract offers.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock on the New York Stock Exchange ("NYSE") of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of POET Technologies Inc. (NASDAQ: POET) between April 1, 2026 and 08:57 AM ET on April 27, 2026, inclusive (the "Class Period"), of the important June 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased POET Technologies securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SES AI Corporation (NYSE: SES) between January 29, 2025 and March 4, 2026, both dates inclusive (the "Class Period"), of the important June 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased SES AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

The global aluminum market is being squeezed by two powerful forces at once: conflict in the Middle East and rising US tariffs. Industry executives say disruptions to production and shipping in the Gulf region are removing significant supply from global markets just as tariffs are already pushing prices higher for American buyers.

The S&P 500 is experiencing extreme dispersion, driven by a semiconductor rally, with index volatility subdued but single-stock implied volatility surging. Implied volatility for top semiconductor stocks is near historical highs, with call-side skew indicating aggressive bullish positioning.

The nineties are back in style. Young people are wearing wired headphones and yearning for an analog time they never got to experience. But what about the stock market? Investors continue to debate whether tech stocks are partying like it's 1999.

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of New Era Energy & Digital, Inc. (NASDAQ: NUAI) between November 6, 2024 and December 29, 2025, inclusive (the "Class Period"), of the important June 1, 2026 lead plaintiff deadline. SO WHAT: If you purchased New Era Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Veritone To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Veritone between October 14, 2025 and April 14, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Veritone, Inc. ("Veritone" or the "Company") (NASDAQ: VERI) and reminds investors of the July 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and sponsored by Summit's partner Akeso, Inc. (HKEX Code: 9926.HK), will be presented today as part of the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The presentation is entitled “Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untrea.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Immutep To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Immutep between March 24, 2025 and March 12, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP) and reminds investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Stocks rallied for a ninth straight week as ceasefire hopes, AI leadership, and stronger earnings lifted risk appetite, pushing the S&P 500 nearly 20% above March lows. Fresh U.S. “defensive” strikes on Iranian targets whipsawed markets, but investors viewed the limited response as evidence that the ceasefire remained durable rather than a renewed escalation. Ahead of the annual REITweek industry conference, REITs were mixed despite a sharp retreat in benchmark interest rates. Homebuilders gained on hopes for mortgage-rate relief.

The 1-Minute Market Report, May 31, 2026

Houston, Texas and Tuebingen , Germany, May 31, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced the presentation of extended data from the ongoing Phase 1 clinical trial evaluating its TCR bispecific (TCER®) candidate IMA401 targeting MAGEA4/8 in heavily pretreated patients with solid tumors, including head and neck cancer and lung cancer, in an oral presentation at the Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, USA. The data show a consistent and favorable tolerability profile across multiple tumor types and encouraging anti-tumor activity at the recommended Phase 2 dose (RP2D) with or without the immune checkpoint inhibitor (ICI) pembrolizumab. Results from the Phase 1 study are being published simultaneously in Nature Medicine .

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Upstart To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Upstart between May 14, 2025 and November 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Upstart Holdings, Inc. ("Upstart" or the "Company") (NASDAQ: UPST) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In New Era To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in New Era between November 6, 2024 and December 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against New Era Energy & Digital, Inc. ("New Era" or the "Company") (NASDAQ: NUAI) and reminds investors of the June 1, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As artificial intelligence reshapes the global economy and electrification accelerates, copper's status as the foundational metal of the 21st century becomes magnified. Demand is surging, yet domestic U.S. supply continues to lags after decades of stagnation.

Revolution Medicine's experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume ​activities they had previously abandoned, setting a new benchmark for this deadly cancer, researchers reported on Sunday.

JPMorgan Chase CEO Jamie Dimon joins Maria Bartiromo at the Reagan National Economic Forum for an exclusive wide-ranging interview on 'Mornings with Maria.' 00:00 'HE'S RIGHT': Big bank CEO BACKS Warsh's critique of the Fed 21:29 RED ALERT: Jamie Dimon warns of a POWERFUL weapon in the making

Investor focus will shift from Wall Street to Main Street over the course of the week, with quarterly results from a few big names in tech and retail landing ahead of a key labor market update.

Current Setup and Live Chart The USD/JPY has found a top at the critical psychological zone around 159–160. Price hit this zone a few weeks back, and the pair received intervention from Japanese financial authorities.

The sport is winning over the next generation, opening up a bigger potential market.

To measure underlying inflation, the new chairman has urged the central bank to look at alternatives to its standard gauge.

May marks the onset of the 'go away' six-month period for US stocks, when they have historically had weaker-than-average returns. In more recent history, though, it has been the encore performance for the October - April period, where market returns have historically shined.

EUR/USD is attempting to recover after defending a critical support zone at the monthly lows, with price now approaching the initial resistance. The rebound has improved near-term momentum and eased immediate downside pressure, but the broader outlook remains sensitive to how the pair reacts at this barrier.

Foreign exchange analysts at Credit Agricole are cautious on the British Pound, forecasting further weakness against both the Euro and US Dollar as UK political uncertainty and fading Bank of England rate-hike expectations undermine Sterling's appeal. At current levels, GBP/USD trades around 1.3456, but Credit Agricole forecasts the.

One of the best lesson investors received when the Dow Jones Industrial Average DJIA turned 130 years old on May 26 was a reminder of why time diversification is so important in the stock market.

6 Numbers That Should Give Prudent Investors Pause

The Great Powers have returned. Russia's full-scale invasion of Ukraine, President Donald Trump's ill-thought-out attack on Iran, and China's threats towards Taiwan, all suggest that we are in a new era.

Gold managed to claw back some ground over the last couple of sessions, but despite the rebound, the precious metal still end.

Goldman Sachs analysts remain constructive on the Norwegian Krone outlook, arguing that the NOK's energy exposure continues to make it one of the strongest-performing currencies in global FX markets. The bank says NOK's "energy credentials have propelled it to some of the best returns across global FX over the past few months", with.

The US Dollar to Canadian Dollar (USD/CAD) exchange rate traded close to 1.3804 at the end of May, leaving the Canadian Dollar around 1.6% weaker over the month after the pair climbed from lows near 1.3550 earlier in May. Scotiabank believes the recent move may be losing momentum.

The Mexican Peso remains one of the stronger emerging market currencies in 2026, with USD/MXN trading near 17.35 after falling steadily from levels above 18.00 earlier this year. The Peso has also remained firm against major currencies, with EUR/MXN at 20.24 and GBP/MXN at 23.35.

Tariff refunds may ease pressure on U.S. businesses and households, but weak growth, lower savings, and sticky inflation keep the U.S. dollar outlook uncertain across USDJPY, EURUSD, and GBPUSD.

<ul> <li><a href="https://site.financialmodelingprep.com/financial-summary/GCO">Genesco (NYSE: GCO)</a> received a significant <strong>price target</strong> increase from Truist Financial, reflecting strong analyst optimism.</li> <li>The <strong>footwear and apparel retailer</strong> surpassed first-quarter expectations with <strong>$487 million</strong> in <strong>revenues</strong> and <strong>2%</strong> <strong>comparable sales</strong> growth.</li> <li>Improved <strong>profitability</strong>, including a smaller-than-estimated quarterly loss and a <strong>47%</strong> adjusted <strong>gross margin</strong>, led to a raised full-year <strong>earnings outlook</strong>.</li> </ul> <p>Genesco is a leading <strong>footwear and apparel retailer</strong> that operates popular brands such as Journeys, Johnston & Murphy, and Schuh. The company is currently receiving positive attention from <strong>financial analysts</strong> following its recent performance. This positive sentiment is reflected in updated expectations for the company's <strong>stock price</strong> and future <strong>earnings</strong>.</p> <p>Reflecting this positive sentiment, Joseph Civello, an analyst at Truist Financial, raises the <strong>price target</strong> for Genesco to <strong>$40.00</strong>. This represents a significant increase from the previous target of <strong>$32.00</strong>. A price target is an analyst's projection of a stock's future price, indicating their belief in its value.</p> <p>This optimism is supported by Genesco's strong <strong>first-quarter results</strong>, which surpassed expectations. Genesco announced <strong>revenues</strong> of approximately <strong>$487 million</strong>, marking a <strong>3% increase</strong> from the prior year. The company also saw a <strong>2% growth</strong> in overall <strong>comparable sales</strong>, a key metric that tracks sales growth in stores open for at least one year.</p> <p>Genesco's <strong>profitability</strong> also shows positive signs. As highlighted by Zacks, Genesco reported a quarterly loss of <strong>$2.18 per share</strong>, which is smaller than the estimated loss of <strong>$2.58</strong>. Additionally, its adjusted <strong>gross margin</strong>, which measures profit on sales before other costs, improved by <strong>30 basis points</strong> to <strong>47%</strong>.</p> <p>Following these strong results, Genesco raises its full-year <strong>earnings outlook</strong>. The company's planned <strong>cost-cutting initiatives</strong> and the potential for tariff refunds also provide a basis for future <strong>profitability</strong>. These factors contribute to the increased <strong>confidence from market analysts and investors</strong>.</p>

<ul> <li><a href="https://site.financialmodelingprep.com/financial-summary/AMBA">Ambarella (NASDAQ: AMBA)</a> experienced a sharp decline due to lower-than-expected sales guidance, raising investor concerns in the semiconductor sector.</li> <li>Biopharmaceutical companies like <a href="https://site.financialmodelingprep.com/financial-summary/OCS">OCS (NASDAQ: OCS)</a> and <a href="https://site.financialmodelingprep.com/financial-summary/CODX">Co-Diagnostics (NASDAQ: CODX)</a> saw significant drops, influenced by management stock transactions and broader biodefense sector shifts.</li> <li>An inverse ETF, <a href="https://site.financialmodelingprep.com/financial-summary/SMCZ">Daily Target 2X Short SMCI ETF (NASDAQ: SMCZ)</a>, declined, indicating strong performance in its underlying Super Micro Computer stock, while <a href="https://site.financialmodelingprep.com/financial-summary/AKTX">Akari Therapeutics (NASDAQ: AKTX)</a> fell despite positive drug news, highlighting biotech stock volatility.</li> </ul> <p>Today's market sees significant declines, particularly in technology stocks and biotechnology stocks. Semiconductor firm <a href="https://site.financialmodelingprep.com/financial-summary/AMBA">Ambarella (NASDAQ: AMBA)</a> records a <strong>21.41% drop</strong>, with its <strong>stock price</strong> settling at <strong>$72.18</strong>. This fall follows the company's second-quarter sales guidance, which was lower than what Wall Street analysts expected, causing concern among investors about future revenue and market performance.</p> <p>Biopharmaceutical firms also face downturns. <a href="https://site.financialmodelingprep.com/financial-summary/OCS">OCS (NASDAQ: OCS)</a> drops <strong>23.42%</strong> to <strong>$22.71</strong> after announcing management stock transactions related to vested RSUs. RSUs are shares given to employees that can be sold after a certain time, which can increase selling pressure. Meanwhile, <a href="https://site.financialmodelingprep.com/financial-summary/CODX">Co-Diagnostics (NASDAQ: CODX)</a> decreases <strong>23.77%</strong> to <strong>$8.53</strong> amid biodefense sector shifts.</p> <p><a href="https://site.financialmodelingprep.com/financial-summary/AKTX">Akari Therapeutics (NASDAQ: AKTX)</a> falls <strong>25.49%</strong> to <strong>$16.43</strong> despite positive news about its lead drug candidate, showing the high-risk nature of biotech stocks. The <a href="https://site.financialmodelingprep.com/financial-summary/SMCZ">Daily Target 2X Short SMCI ETF (NASDAQ: SMCZ)</a> also drops <strong>23.46%</strong> to <strong>$6.23</strong>. This is an inverse ETF, designed to move in the opposite direction of a stock. Its decline means the underlying Super Micro Computer stock performed very well, reflecting diverse market trends.</p> <p>In summary, today's market losers were driven by specific events. Poor financial guidance hurt Ambarella, while biotech firms faced volatility from insider transactions and sector uncertainty. The inverse ETF's loss highlights a strong gain in its underlying stock, showing how different factors impact equity market performance.</p>

<ul> <li><strong>Sunlands Technology Group (NASDAQ:STG)</strong> surged over <strong>124%</strong> following an asset disposal announcement, accompanied by exceptionally high trading volume.</li> <li><strong>Replimune Group (NASDAQ:REPL)</strong> shares jumped over <strong>85%</strong> on news of its plan to resubmit a melanoma drug for FDA approval, also experiencing massive trading volume.</li> <li><strong>Astrotech Corporation (NASDAQ:ASTC)</strong> continued its rally with a <strong>69%</strong> climb after announcing a new initiative in lunar resource development.</li> </ul> <p>Several companies saw significant gains today, driven by specific corporate news and market trends. Among the top performers are <a href="https://site.financialmodelingprep.com/financial-summary/STG">Sunlands Technology Group (NASDAQ:STG)</a>, <a href="https://site.financialmodelingprep.com/financial-summary/REPL">Replimune Group (NASDAQ:REPL)</a>, and <a href="https://site.financialmodelingprep.com/financial-summary/ASTC">Astrotech Corporation (NASDAQ:ASTC)</a>, each responding to unique developments within their operations.</p> <p><strong>Sunlands Technology Group</strong> stock surged <strong>124.26%</strong> to close at <strong>$6.10</strong>, with a daily high of <strong>$6.20</strong>. This follows the company's announcement of a material asset disposal for cash. Trading volume was exceptionally high at <strong>24.75 million shares</strong>, far above its average of just <strong>3,696 shares</strong>. <strong>Astrotech Corporation</strong> also saw its rally continue, climbing <strong>69.22%</strong> to <strong>$49.80</strong> after announcing a new push into lunar resource development.</p> <p>Biotechnology company <strong>Replimune Group</strong> jumped <strong>85.68%</strong> to <strong>$8.69</strong> on news that it plans to resubmit its melanoma drug for FDA approval. The stock saw a massive trading volume of <strong>50.86 million shares</strong>. Meanwhile, <a href="https://site.financialmodelingprep.com/financial-summary/OLOX">Olenox Industries Inc. (NASDAQ:<strong>OLOX</strong>)</a> shares rose <strong>78.25%</strong> to <strong>$8.77</strong>. The activity comes as Olenox Industries Inc. received a delinquency notice from Nasdaq for failing to file its annual report.</p> <p>The <a href="https://site.financialmodelingprep.com/financial-summary/DLLL">GraniteShares 2x Long DELL Daily ETF (NASDAQ:DLLL)</a> increased by <strong>64.41%</strong> to <strong>$199.51</strong>. This financial product is an <strong>Exchange-Traded Fund (ETF)</strong> designed to deliver twice the daily performance of <a href="https://site.financialmodelingprep.com/financial-summary/DELL">Dell Technologies (NYSE:DELL)</a> common stock. Because it is a <strong>leveraged ETF</strong>, its performance can differ significantly from 2x the return of Dell Technologies stock over periods longer than one day.</p> <p>In summary, today's top gainers show how specific company news, such as asset sales, strategic initiatives, and regulatory updates, can drive significant stock movement. High trading volumes across these stocks highlight strong investor interest and reaction to these developments.</p>

<ul> <li>Dollar Tree is strategically expanding its product offerings beyond the traditional $1 price point to include items at $3 and $5, aiming to attract a wider customer base.</li> <li>Despite an increased price target from Jefferies to <strong>$85</strong>, the new target remains below the stock's current trading price of <strong>$116.44</strong>, suggesting a cautious analyst outlook.</li> <li>The company demonstrated robust financial health with a <strong>3.5%</strong> increase in comparable sales, a <strong>120 basis points</strong> expansion in gross margin to <strong>36.9%</strong>, and raised its full-year 2026 adjusted earnings per share outlook to a range of <strong>$6.70</strong> to <strong>$7.10</strong>.</li> </ul> <p><a href="https://site.financialmodelingprep.com/financial-summary/DLTR">Dollar Tree (NASDAQ: DLTR)</a> is a major <strong>discount retail</strong> company operating thousands of stores. Dollar Tree is known for selling a wide variety of products at low prices. It is currently shifting its strategy away from a strict $1 price point, now including items at $3 and $5 to attract a broader range of customers.</p> <p>On May 29, 2026, the investment firm Jefferies raised its <strong>price target</strong> for Dollar Tree to <strong>$85</strong> from a previous target of <strong>$75</strong>. This new target is below the stock's price of <strong>$116.44</strong> at the time of the announcement, indicating a cautious view from the analyst despite the increase.</p> <p>This analyst update comes as Dollar Tree reports strong performance. The company’s <strong>comparable sales</strong>, which track sales at stores open for at least a year, increased by 3.5%. This growth is driven by customers spending more per trip, with the average transaction size rising 4.5%, offsetting a 1% dip in traffic.</p> <p>The company’s financial health shows improvement, with a <strong>gross margin</strong> expansion of <strong>120 basis points</strong> to <strong>36.9%</strong>. Gross margin is the profit a company makes on the goods it sells. As highlighted by Proactive Investors, Dollar Tree announced stronger-than-expected <strong>earnings</strong>, with adjusted <strong>earnings per share</strong> of <strong>$1.74</strong> on <strong>revenue</strong> of <strong>$4.97 billion</strong>.</p> <p>Looking ahead, management raised its full-year 2026 <strong>profit outlook</strong> to a new range of <strong>$6.70</strong> to <strong>$7.10</strong> for adjusted <strong>earnings per share</strong>. The company also returned <strong>$595 million</strong> to shareholders by repurchasing its own stock, a common way to create value for <strong>investors</strong>.</p>

<ul> <li>Minera Alamos Inc. achieved record net earnings of <strong>$10.90 million</strong> and quarterly revenue of <strong>$38.90 million</strong>, significantly surpassing analyst estimates.</li> <li>The company maintains a robust financial position with <strong>$45.50 million</strong> in cash, <strong>$88.90 million</strong> in working capital, and a healthy <strong>debt-to-equity ratio of 0.16</strong>.</li> <li>Strategic financing through a <strong>US$75.00 million</strong> revolving credit facility and strong financial stability are supporting the fast-track construction of the Copperstone Gold Project.</li> </ul> <p><a href="https://site.financialmodelingprep.com/financial-summary/MAIFF">Minera Alamos Inc. (OTC:MAIFF)</a> is a gold mining company advancing its portfolio of projects in Mexico and the United States. A key asset for Minera Alamos Inc. is the past-producing Copperstone Gold Project located in Arizona. The company operates to develop its properties and increase gold production within the competitive precious metals sector.</p> <p>On May 29, 2026, Minera Alamos Inc. reported an earnings per share (EPS) of <strong>$0.10</strong>, which is the portion of a company's profit allocated to each share of stock. This figure missed the analyst consensus estimate of <strong>$0.11</strong>. However, a separate company announcement highlighted by Newsfile Corp. noted record net earnings of <strong>$10.90 million</strong>.</p> <p>The company also announced quarterly revenue of <strong>$38.90 million</strong>, surpassing the analyst estimate of <strong>$28.10 million</strong>. This performance set a new quarterly record for Minera Alamos Inc., driven by gold production totaling <strong>8,734 ounces</strong>. The company ended the period with a strong cash position of <strong>$45.50 million</strong> and working capital of <strong>$88.90 million</strong>.</p> <p>To support its growth, Minera Alamos Inc. secured a <strong>US$75.00 million</strong> revolving credit facility with <a href="https://site.financialmodelingprep.com/financial-summary/BNS">The Bank of Nova Scotia (TSX: BNS)</a> and <a href="https://site.financialmodelingprep.com/financial-summary/NA">National Bank of Canada (TSX: NA)</a>. This new financing strengthens its balance sheet by refinancing existing, higher-cost debt. This is reflected in its healthy <strong>debt-to-equity ratio of 0.16</strong>, which indicates the company relies more on its own funds than on debt.</p> <p>The company's financial stability is further shown by its <strong>current ratio of 3.31</strong>, indicating a strong ability to meet short-term financial obligations. This supports the board's approval of a fast-track construction plan for the Copperstone Gold Project, following a positive Pre-Feasibility Study showing strong project economics.</p>

<ul> <li>Argus Research has increased its price target for <a href="https://site.financialmodelingprep.com/financial-summary/WSM">Williams-Sonoma (NYSE: WSM)</a> to <strong>$230</strong>, indicating a potential upside of <strong>11.88%</strong> from its previous trading price.</li> <li>The company demonstrated robust Q1 financial performance, reporting <strong>$1.81 billion</strong> in net revenues and an earnings per share (EPS) of <strong>$1.93</strong>, surpassing analyst estimates.</li> <li>Despite strong operational results, the home furnishings retailer faces broader economic challenges, including low consumer confidence and a soft housing market, influencing some analysts to maintain a "Hold" rating.</li> </ul> <p>Christopher Graja of Argus Research raises the price target for Williams-Sonoma to <strong>$230</strong> from <strong>$225</strong>. At the time, Williams-Sonoma was trading at <strong>$205.58</strong> per share. This new target suggests a potential upside of about <strong>11.88%</strong> from that price, reflecting analyst confidence in the company's investment outlook.</p> <p>Williams-Sonoma is a specialty retailer that sells high-quality home products. The company operates several well-known brands, including Pottery Barn, West Elm, and its namesake Williams-Sonoma stores. These brands are central to its market strategy and performance, competing in the home furnishings sector.</p> <p>This positive analyst view is supported by the company's recent performance. In its first quarter, Williams-Sonoma reported net revenues of <strong>$1.81 billion</strong>, a <strong>4.4%</strong> increase from the prior year. Its earnings per share (EPS) rose <strong>4.3%</strong> to <strong>$1.93</strong>, beating estimates by <strong>7.2%</strong>, as highlighted by Zacks.</p> <p>The revenue growth is broad-based across its portfolio. Williams-Sonoma saw a <strong>4.8%</strong> increase in comparable brand revenues, a key metric showing sales growth from existing operations. This was led by an <strong>8.5%</strong> increase at West Elm, a <strong>5%</strong> increase at the Williams-Sonoma brand, and a <strong>4.5%</strong> increase at Pottery Barn.</p> <p>Despite this strength, Williams-Sonoma faces a difficult economic environment. A Seeking Alpha report notes challenges like low consumer confidence and a soft housing market. This led to a "Hold" rating, as the firm's valuation metrics are not seen as appealing in absolute terms for this retailer stock.</p>

<ul> <li><strong>Williams Companies</strong> operates a vast, fee-based <strong>midstream energy</strong> pipeline network, including the critical Transco system, ensuring stable revenue.</li> <li>The company reported record <strong>adjusted EBITDA</strong> in 2025 and received an increased <strong>price target</strong> from Argus Research, indicating strong financial performance and a positive analyst outlook.</li> <li><strong>Williams Companies</strong> is strategically pursuing growth in <strong>LNG exports</strong> and power generation assets to meet rising demand from <strong>data centers</strong> and <strong>AI power needs</strong>, differentiating its <strong>investment strategy</strong>.</li> </ul> <p><a href="https://site.financialmodelingprep.com/financial-summary/WMB">Williams Companies (NYSE: WMB)</a> is a major <strong>midstream energy firm</strong> in the United States. It operates over 33,000 miles of <strong>natural gas pipelines</strong>, including the vital Transco system which moves roughly 30% of the nation's <strong>natural gas</strong>. Williams Companies' business is largely fee-based, providing stable revenue by charging for infrastructure use.</p> <p>On May 29, 2026, Argus Research increased its <strong>price target</strong> for Williams Companies to <strong>$85.00</strong> from a previous <strong>$83.00</strong>. At the time, this new target represented a potential upside of <strong>18.78%</strong> from the stock's price of <strong>$71.56</strong>. This positive outlook follows a period of strong performance under new leadership, highlighting a compelling <strong>investment opportunity</strong>.</p> <p>The company reported record results for 2025, posting a full-year <strong>adjusted EBITDA</strong> of <strong>$7.75 billion</strong>, a <strong>9%</strong> increase. <strong>EBITDA</strong>, or Earnings Before Interest, Taxes, Depreciation, and Amortization, is a key measure of operating performance. Williams Companies also reported a fourth-quarter <strong>earnings per share (EPS)</strong> of <strong>$0.55</strong>.</p> <p>Williams Companies is focusing on growth from <strong>LNG exports</strong> and rising <strong>power demand from data centers</strong>. Unlike competitor Kinder Morgan, which relies on a pipeline backlog, Williams Companies is taking a different approach. The company is strategically buying into power generation assets itself to meet this new demand, positioning itself for future <strong>energy sector growth</strong>.</p> <p>As highlighted by Seeking Alpha, Williams Companies is considered an elite stock positioned to benefit from <strong>AI-driven power needs</strong>. Fool - Investing News describes the company as a pure play on the demand for <strong>natural gas-fired electricity</strong>, noting its stock has delivered a total return of over <strong>280%</strong> in five years, showcasing its strong <strong>stock performance</strong>.</p>

<ul> <li>Analyst firm Macquarie reiterated an "Outperform" rating for <a href="https://site.financialmodelingprep.com/financial-summary/OKTA">Okta (NASDAQ: OKTA)</a>, raising its <strong>price target</strong> to <strong>$120.00</strong>.</li> <li>The <strong>identity management</strong> leader reported strong Q1 2027 financials, with <strong>revenue</strong> up <strong>11%</strong> to <strong>$765.00 million</strong> and adjusted <strong>earnings per share</strong> of <strong>$0.91</strong>, beating analyst expectations.</li> <li>Strong future indicators, including <strong>cRPO</strong> growth of <strong>12%</strong> and a raised full-year <strong>revenue outlook</strong>, signal continued momentum, fueled by increasing demand for <strong>AI security solutions</strong>.</li> </ul> <p>Okta is a leading <strong>software identity provider</strong> that specializes in <strong>cybersecurity solutions</strong>. The company helps organizations manage and secure user authentication into modern applications. Its services are becoming increasingly important as businesses increase their use of <strong>cloud-based tools</strong> and face growing <strong>cybersecurity threats</strong>, particularly with the rise of <strong>artificial intelligence</strong>.</p> <p>On May 29, 2026, the analyst firm Macquarie reiterated its "Outperform" rating for Okta. The firm also increased its <strong>price target</strong> for the stock to <strong>$120.00</strong> from its previous target of <strong>$100.00</strong>. At the time of the rating, the stock was trading at <strong>$121.73</strong>, already above the newly revised target.</p> <p>This analyst confidence follows a strong <strong>financial report</strong> from the company. For its fiscal first quarter of 2027, Okta posted <strong>revenue</strong> of <strong>$765.00 million</strong>, an <strong>11%</strong> increase from the previous year. Its adjusted <strong>earnings per share</strong> came in at <strong>$0.91</strong>, beating analyst expectations of <strong>$0.85</strong>, as highlighted by Proactive Investors.</p> <p>The company's <strong>financial performance</strong> is also supported by strong future indicators. Its <strong>current remaining performance obligations (cRPO)</strong>, which measure future revenue under contract, grew <strong>12%</strong> to nearly <strong>$2.50 billion</strong>. Okta also raised its full-year <strong>revenue outlook</strong> to a range between <strong>$3.185 billion</strong> and <strong>$3.205 billion</strong>, showing confidence in its continued growth.</p> <p>Following the news, Okta's <strong>stock</strong> surged, hitting a <strong>52-week high</strong> of <strong>$123.52</strong>, as noted by Benzinga. Analysts are attributing the positive results to better sales execution and increasing demand for <strong>AI security</strong>. As reported by Barron's, many are now focusing more on the company's <strong>AI product pipeline</strong> than its recent <strong>financial success</strong>.</p>

<ul> <li><strong>BitFuFu Inc. (NASDAQ:FUFU)</strong> reported a significant earnings miss, with a <strong>loss per share of $0.21</strong> against an estimated <strong>$0.03 profit per share</strong>.</li> <li>The <strong>cryptocurrency mining</strong> company's <strong>revenue</strong> reached <strong>$72.66 million</strong>, falling short of analyst expectations and marking a <strong>6.8% year-over-year decline</strong>.</li> <li><strong>Net loss</strong> for the quarter widened to <strong>$35.0 million</strong>, primarily driven by a <strong>$35.6 million</strong> non-cash fair value loss reflecting Bitcoin price fluctuations.</li> </ul> <p><a href="https://site.financialmodelingprep.com/financial-summary/FUFU">BitFuFu Inc. (NASDAQ:FUFU)</a> operates as a leading <strong>Bitcoin miner</strong> and an innovator in <strong>cryptocurrency mining services</strong>. The company provides these essential services to a global user base, firmly positioning itself within the competitive <strong>digital asset industry</strong>. Its primary activities involve mining various <strong>cryptocurrencies</strong> and offering advanced <strong>cloud-mining solutions</strong>.</p> <p>On May 29, 2026, BitFuFu announced its latest <strong>quarterly financial results</strong>. The company reported a <strong>loss per share of $0.21</strong>, significantly missing the <strong>analyst consensus estimate of a $0.03 profit per share</strong>. This indicates that BitFuFu's <strong>financial performance</strong> did not meet market expectations for <strong>profitability</strong> during the reporting period.</p> <p>BitFuFu's <strong>revenue</strong> for the quarter stood at <strong>$72.66 million</strong>, falling short of the estimated <strong>$93.35 million</strong>. As highlighted by GlobeNewswire, this <strong>revenue figure</strong> also represents a <strong>6.8% decline</strong> from the <strong>$78.0 million</strong> reported in the same quarter of 2025, clearly demonstrating a <strong>year-over-year decrease in sales</strong> for the <strong>digital asset company</strong>.</p> <p>BitFuFu's <strong>net loss</strong> for the quarter increased to <strong>$35.0 million</strong>, a significant change from a <strong>$16.9 million loss</strong> in the prior year. This substantial increase was heavily influenced by a <strong>non-cash fair value loss of $35.6 million</strong>. This type of loss directly reflects a decrease in the market price of <strong>Bitcoin</strong> held by the company, impacting its overall <strong>financial health</strong>.</p> <p>Current <strong>financial data</strong> reveals a negative <strong>price-to-earnings (P/E) ratio of -10.00</strong>, which signals that BitFuFu has incurred a net loss over the past year. However, the company maintains a strong <strong>current ratio of 3.30</strong>. A <strong>current ratio</strong> above <strong>1.0</strong> generally suggests that a company possesses sufficient <strong>short-term assets</strong> to cover its <strong>short-term liabilities</strong>, indicating some liquidity strength despite profitability challenges.</p>

<ul> <li><a href="https://site.financialmodelingprep.com/financial-summary/FUTU">Futu Holdings Limited (NASDAQ:FUTU)</a> is currently under investigation by the China Securities Regulatory Commission (CSRC) regarding its business practices in mainland China.</li> <li>Following the announcement of the regulatory notice, FUTU's stock price experienced a significant decline of approximately <strong>28%</strong>.</li> <li><a href="https://site.financialmodelingprep.com/financial-summary/GS">Goldman Sachs (NYSE:GS)</a> downgraded the digital brokerage firm's stock to a "Neutral" rating, despite setting a price target of <strong>$102.13</strong>.</li> </ul> <p><a href="https://site.financialmodelingprep.com/financial-summary/FUTU">Futu Holdings Limited (NASDAQ:FUTU)</a> is a technology firm that provides a digital brokerage and wealth management platform. The company primarily serves investors in Hong Kong and mainland China, offering them access to trade stocks and other financial products through its online services.</p> <p>The law firm Bragar Eagel & Squire, P.C. is investigating FUTU for possible violations of federal securities laws. This regulatory investigation follows an announcement from the company regarding a notice it received concerning its business practices.</p> <p>The investigation was prompted after FUTU announced it received a "Notice of Investigation and an Administrative Penalty Pre-Notification Letter" from the China Securities Regulatory Commission (CSRC). This notice specifically relates to the company's operations in mainland China.</p> <p>Following this news on May 22, 2026, FUTU's stock price fell by approximately <strong>28%</strong>, or <strong>$34.10</strong> per share, closing at <strong>$89.76</strong>. Shortly after, on May 25, 2026, <a href="https://site.financialmodelingprep.com/financial-summary/GS">Goldman Sachs (NYSE:GS)</a> downgraded the stock to a "Neutral" rating from its previous "Buy" rating.</p> <p>Despite the downgrade, Goldman Sachs analyst Shuo Yang set a new price target of <strong>$102.13</strong>. A price target is an analyst's estimate of a stock's future value. The stock is currently trading at <strong>$106.31</strong>, with a market capitalization of approximately <strong>$14.84 billion</strong>.</p>

<ul> <li><a href="https://site.financialmodelingprep.com/financial-summary/SAIC">Science Applications International Corporation (NASDAQ:SAIC)</a> is scheduled to release its earnings report on June 1, 2026, with analysts projecting an <strong>earnings per share (EPS)</strong> of <strong>$2.26</strong> and quarterly revenue of approximately <strong>$1.82 billion</strong>.</li> <li>The company is pursuing a strategy focused on improving margins, targeting fiscal year 2027 revenue between <strong>$7 billion</strong> and <strong>$7.2 billion</strong>, backed by <strong>$100 million</strong> in cost reduction initiatives.</li> <li>Despite recent revenue declines, SAIC's stock is considered fundamentally sound, trading at a <strong>Price-to-Earnings (P/E)</strong> ratio of <strong>13.27</strong> and a <strong>Price-to-Sales (P/S)</strong> ratio of <strong>0.63</strong>, with a healthy <strong>current ratio</strong> of <strong>1.20</strong>.</li> </ul> <p>Science Applications International Corporation is a leading technology and engineering company that primarily provides services to the U.S. government. The firm focuses on technical, engineering, and enterprise IT markets, operating in a highly competitive space. SAIC often bids for large government contracts against other defense and technology service providers, making its strategic positioning crucial for sustained growth in the defense sector.</p> <p>On June 1, 2026, SAIC is scheduled to release its highly anticipated earnings report. Wall Street analysts forecast an <strong>earnings per share (EPS)</strong> of <strong>$2.26</strong>, a key measure of a company's profitability allocated to each share of stock. Analysts also project quarterly revenue of approximately <strong>$1.82 billion</strong>, providing insights into the company's top-line performance.</p> <p>This upcoming financial report is set against a strategic backdrop that prioritizes margins over top-line growth. SAIC is targeting revenue between <strong>$7 billion</strong> and <strong>$7.2 billion</strong> for fiscal year 2027. To support this ambitious goal and enhance its overall profitability, the company has <strong>$100 million</strong> in cost reductions underway, demonstrating a clear focus on operational efficiency and financial health.</p> <p>Despite recent revenue declines, SAIC's stock is considered fundamentally sound by market analysts. As highlighted by GuruFocus, shares recently rose <strong>4.1%</strong> to <strong>$100.01</strong> but are still seen as undervalued compared to a GF Value estimate of <strong>$123.66</strong>. The stock's <strong>Price-to-Earnings (P/E)</strong> ratio stands at <strong>13.27</strong>, and its <strong>Price-to-Sales (P/S)</strong> ratio is <strong>0.63</strong>, offering valuable investment insights for potential investors.</p> <p>The company's financial health further underscores its stability, with a <strong>Debt-to-Equity ratio</strong> of <strong>1.80</strong>, which measures its financial leverage. A <strong>current ratio</strong> of <strong>1.20</strong> suggests SAIC possesses sufficient liquid assets to cover its short-term liabilities, indicating strong liquidity. A positive signal for investor confidence is the lack of any insider selling over the past three months, reflecting internal belief in the company's future prospects.</p>

<ul> <li>Despite a decade of significant growth, <a href="https://site.financialmodelingprep.com/financial-summary/DECK">Deckers Outdoor (NYSE:DECK)</a> has seen its stock decline by nearly <strong>20%</strong> over the past year, falling more than half from its January 2025 peak.</li> <li>The global footwear company reported a record <strong>10%</strong> revenue increase to <strong>$5.47 billion</strong> and an <strong>11%</strong> rise in diluted EPS to <strong>$7.02</strong> for fiscal year 2026, primarily driven by its HOKA and UGG brands.</li> <li>While strong annual results were achieved, fourth-quarter operating income decreased due to higher expenses; however, Deckers Outdoor maintains a robust balance sheet with <strong>$1.91 billion</strong> in cash and no debt, alongside significant share repurchases.</li> </ul> <p> <a href="https://site.financialmodelingprep.com/financial-summary/DECK">Deckers Outdoor (NYSE:DECK)</a> is a global footwear company best known for its popular Ugg and Hoka brands. While Deckers Outdoor's stock price grew over <strong>1,000%</strong> in the past decade, it has recently faced challenges. The shares have declined nearly <strong>20%</strong> over the last year and are down more than half from their January 2025 peak. </p> <p> On May 29, 2026, Argus Research lowered its price target for Deckers Outdoor to <strong>$128.00</strong>. When this new target was published, the stock was trading at <strong>$114.35</strong>. This adjustment still indicates a potential upside of <strong>11.94%</strong> for the company's shares, suggesting some confidence despite the lower target. </p> <p> This outlook follows a strong financial year for the company. For its full fiscal year 2026, Deckers Outdoor reported a <strong>10%</strong> revenue increase to a record <strong>$5.47 billion</strong>. Diluted earnings per share (EPS), which shows the company's profit per share of stock, also rose <strong>11%</strong> to a record <strong>$7.02</strong>. </p> <p> The growth is primarily driven by its two largest brands. As highlighted by GuruFocus, the HOKA brand's full-year sales increased by <strong>15.9%</strong> to <strong>$2.59 billion</strong>, while the UGG brand's sales grew <strong>8.2%</strong> to <strong>$2.74 billion</strong>. However, the company's other brands are seeing sales contract, leading to a muted market reaction to the strong earnings report. </p> <p> Despite record annual results, fourth-quarter operating income fell to <strong>$156.70 million</strong> from <strong>$173.90 million</strong> a year ago due to higher operating expenses. To return value to shareholders, Deckers Outdoor repurchased over <strong>$1 billion</strong> in shares and holds a strong balance sheet with <strong>$1.91 billion</strong> in cash and no debt. </p>

<h1 class="isSelectedEnd">TD Securities Maintains Bullish View on ATS Corporation (OTC: ATSAF) After Mixed Q4 Results</h1> <ul> <li class="isSelectedEnd">TD Securities reportedly raised its price target for ATS Corporation (OTC: ATSAF), while maintaining a <strong>Buy rating,</strong> reflecting confidence in the company&rsquo;s long-term automation growth outlook.</li> <li class="isSelectedEnd">ATS Corporation reported fourth-quarter fiscal 2026 revenue of <strong>C$747.1 million</strong>, up from C$574.2 million in the prior-year period.</li> <li class="isSelectedEnd">Despite stronger revenue, order bookings declined 18.4% year over year, while the company ended the quarter with an order backlog of C$1.96 billion.</li> </ul> <p class="isSelectedEnd">ATS Corporation (OTC: ATSAF) is a provider of automation solutions for customers across life sciences, transportation, food and beverage, consumer products, and energy markets. The company designs, builds, and services advanced automation systems used by manufacturers that require precision, efficiency, and scale.</p> <p class="isSelectedEnd">TD Securities&rsquo; positive view comes as ATS reported stronger revenue for the fourth quarter of fiscal 2026. <strong>Revenue increased to C$747.1 million</strong>, compared with C$574.2 million in the same period last year. For the full fiscal year, ATS also reported approximately 11% growth in both revenue and adjusted earnings from operations, which management described as evidence of solid execution.</p> <p class="isSelectedEnd">However, the quarter was not entirely positive. Order bookings declined 18.4% year over year to C$704 million, compared with C$863 million a year earlier. Management explained that the prior-year period benefited from several large orders, making the comparison more difficult. The company&rsquo;s order backlog stood at C$1.96 billion at quarter-end, down from C$2.14 billion a year ago, but still providing revenue visibility heading into fiscal 2027.</p> <p class="isSelectedEnd">ATS also reported a net loss of C$16.2 million for the quarter, a significant improvement from a net loss of C$68.9 million in the prior-year period. Adjusted earnings from operations reached C$76.8 million, with an adjusted earnings from operations margin of 10.3%. Adjusted basic earnings per share were C$0.36 for the quarter.</p> <p class="isSelectedEnd">Looking ahead, ATS is focused on restructuring actions designed to improve margins, free cash flow generation, and asset efficiency. CEO Doug Wright is expected to emphasize operational discipline, portfolio focus, and stronger execution across the company&rsquo;s automation businesses.</p> <p>Overall, ATS delivered solid revenue growth and improved profitability metrics, but the decline in order bookings and lower backlog show that demand trends remain uneven. For investors, the key question is whether ATS can convert its backlog into profitable growth while improving margins and cash flow in fiscal 2027.</p>

<ul> <li><strong>Strong Financial Performance:</strong> <a href="https://site.financialmodelingprep.com/financial-summary/BKE">The Buckle, Inc. (NYSE:BKE)</a> exceeded analyst expectations with an <strong>EPS</strong> of <strong>$0.92</strong> and <strong>net income</strong> of <strong>$46.90 million</strong>, reflecting significant year-over-year growth.</li> <li><strong>Revenue Growth Drivers:</strong> The <strong>specialty apparel retailer</strong> reported <strong>revenue</strong> of <strong>$288.74 million</strong>, driven by a <strong>5.1% rise</strong> in comparable-store sales and a <strong>2.8% increase</strong> in <strong>online sales</strong>, supported by strong demand for women's merchandise.</li> <li><strong>Positive Valuation Metrics:</strong> With a <strong>price-to-earnings (P/E) ratio</strong> of <strong>11.33</strong> and a <strong>current ratio</strong> of <strong>1.89</strong>, The Buckle demonstrates solid financial health and efficient short-term liquidity.</li> </ul> <p> <a href="https://site.financialmodelingprep.com/financial-summary/BKE">The Buckle, Inc. (NYSE:BKE)</a> is a <strong>U.S. retailer</strong> specializing in <strong>clothing, footwear, and accessories</strong> for young men and women. The company operates physical stores and an <strong>online platform</strong>, facing competition from other <strong>specialty apparel retailers</strong>. It focuses on providing a mix of private-label and brand-name merchandise. </p> <p> On May 29, 2026, The Buckle announced strong first-quarter results. The company reported an <strong>earnings per share (EPS)</strong> of <strong>$0.92</strong>, which was higher than the analyst consensus estimate of <strong>$0.74</strong>. This <strong>financial performance</strong> reflects a <strong>net income</strong> of <strong>$46.90 million</strong>, a significant increase from <strong>$35.20 million</strong> in the same quarter of the previous year. </p> <p> The company also posted <strong>revenue</strong> of <strong>$288.74 million</strong>, slightly above the estimated <strong>$287.68 million</strong>. This represents a <strong>6.1% increase</strong> in net sales from the prior year's <strong>$272.10 million</strong>. This <strong>retail growth</strong> was driven by a <strong>5.1% rise</strong> in comparable-store sales and a <strong>2.8% increase</strong> in <strong>online sales</strong>, which reached <strong>$47.70 million</strong>. </p> <p> As highlighted by MarketBeat, the improved sales and earnings were supported by growth in comparable stores and continued demand for its women's merchandise. The company also benefited from lower administrative costs following a litigation settlement, which helped improve its net income for the quarter. </p> <p> From a <strong>valuation standpoint</strong>, The Buckle has a <strong>price-to-earnings (P/E) ratio</strong> of <strong>11.33</strong>. This ratio measures the company's current share price relative to its per-share earnings. Additionally, its <strong>current ratio</strong> of <strong>1.89</strong> indicates it has sufficient short-term assets to cover its short-term debts, showcasing strong <strong>financial health</strong>. </p>

The last trading week of May is coming to an end, and gold has managed to recover some short-term bullish strength. During the session, the metal posted a gain of more than 1.2%, showing a renewed buying bias toward the end of the week.

<h1 class="isSelectedEnd">Minera Alamos Inc. (OTCQX: MAIFF) Reports Record Q1 2026 Results and Advances Copperstone Growth Plan</h1> <ul> <li class="isSelectedEnd">Minera Alamos Inc. (OTCQX: MAIFF) reported record first-quarter 2026 results, with r<strong>evenue of $39.2 million</strong>, <strong>net earnings of $10.9 million</strong>, and <strong>EBITDA of $15.3 million</strong>.</li> <li class="isSelectedEnd">The company ended the quarter with <strong>$45.5 million in cash and cash equivalents</strong> and <strong>working capital of $88.9 million</strong>, supporting a stronger financial position.</li> </ul> <p class="isSelectedEnd">Minera Alamos also closed a US$75 million revolving credit facility and advanced its Copperstone Gold Project in Arizona, where a recent pre-feasibility study showed strong project economics.</p> <p class="isSelectedEnd">Minera Alamos Inc. (OTCQX: MAIFF) is a North American gold production and development company with assets in Nevada, Arizona, and Mexico. The company recently reported unaudited financial and operating results for the first quarter of 2026, delivering a record quarter driven by strong gold sales from the Pan mine in Nevada and a favorable gold price environment.</p> <p class="isSelectedEnd">For Q1 2026, Minera Alamos reported <strong>revenue of $39.2 million</strong>, compared with $2.4 million in the prior-year period. Net earnings reached $10.9 million, or $0.10 per share, while EBITDA totaled $15.3 million. The company sold 9,134 ounces of gold during the quarter at an average realized price of $4,287 per ounce.</p> <p class="isSelectedEnd">The company&rsquo;s liquidity position also improved. Minera Alamos ended the quarter with $<strong>45.5 million in cash and cash equivalents</strong> and $88.9 million in working capital. This gives the company additional flexibility as it continues to develop its growth pipeline and fund project-level activity.</p> <p class="isSelectedEnd">Minera Alamos further strengthened its balance sheet by closing a US$75 million revolving credit facility with Scotiabank and National Bank of Canada. The company plans to use an initial US$45 million drawdown mainly to repay existing debt and commitments with Auramet, including a gold prepayment facility of 7,830 ounces and remaining forward sales of 3,000 ounces of gold. The financing should also help support development work across its growth assets without relying heavily on equity dilution.</p> <p class="isSelectedEnd">A major focus is the Copperstone Gold Project in Arizona. Minera Alamos recently announced a positive pre-feasibility study for the project, showing an after-tax NPV 5% of $374 million at a base-case gold price of $3,500 per ounce. The study also outlined an internal rate of return of 108% and a payback period of 1.2 years. Based on these results, the company&rsquo;s board approved a fast-track construction plan, with initial production anticipated in mid-2027.</p> <p>The company&rsquo;s financial profile appears stronger after its record Q1 performance, improved liquidity, and new credit facility. At the same time, investors should continue watching gold price exposure, project execution at Copperstone, production trends at the Pan mine, and how the new debt facility affects the company&rsquo;s leverage over time.</p>

Gold is showing early signs of a bullish reversal as buyers defend long-term support and pressure key resistance near the 50-day moving average.